 鲜花( 85)  鸡蛋( 2)
|

楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval
; i# D; g) c( B# Y" `' F! u# ? 5 s. J/ ` w! U' l- b
EDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
, Z' @# B1 d' Y0 o
. R# W- E# }0 h% Z! vBY THE EDMONTON JOURNAL FEBRUARY 16, 2007! i. g* `* T( J* M
9 I/ f. E+ t4 y# ` ' U( [2 W# t# A0 `
EDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
* A: @1 L5 q4 s4 B/ h: O5 M& a0 P( |4 E/ |9 i! _/ ~
The agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."; F0 m, B% u8 P1 s5 h
! c7 o: m, X6 h5 VThe APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.
1 X( x/ J5 b( N& a$ K) V5 r+ u
3 _; o! `; G9 oIt should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.* w* M, L0 h) r' K' p' s2 C" j
. L& A& k# m! X6 n* S
It certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.
0 J$ m- i P, u" l) T9 {5 c$ @: j# D j& ^ w
"As a scientist, it's one of the highlights of my CAREER," Shan said.
' {. n% F. K+ q
& n: ?8 u1 z7 \3 o) ~: D"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."' f4 j5 p% J! t& n: L9 q7 b
) H( J7 c i3 b! h$ F8 y2 |; k
It's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.# @5 t2 b# I) J5 h+ H6 C
7 F" G8 N7 |3 xGinseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.
1 i9 l+ \1 F% J$ }7 T7 u7 N8 P; b
, Y6 k1 {7 U. g' i' d2 XThe approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.* T) {7 P3 [& r# j$ Y
5 U @ B7 n) a6 a: x
' }# u( L, @4 {http://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|